139 related articles for article (PubMed ID: 32979736)
1. Availability of substances for use in personal vaporisers on three online cryptomarkets.
Lim CCW; Leung JKY; Connor JP; Hall WD; Gartner C; Cheng BHC; Scheurer RW; Sun T; Chan GCK
Drug Alcohol Depend; 2020 Dec; 217():108254. PubMed ID: 32979736
[TBL] [Abstract][Full Text] [Related]
2. Hidden wholesale: The drug diffusing capacity of online drug cryptomarkets.
Aldridge J; Décary-Hétu D
Int J Drug Policy; 2016 Sep; 35():7-15. PubMed ID: 27260863
[TBL] [Abstract][Full Text] [Related]
3. A market on both "sides" of the law: The use of the hidden web for the sale of new psychoactive substances.
Wadsworth E; Drummond C; Kimergård A; Deluca P
Hum Psychopharmacol; 2017 May; 32(3):. PubMed ID: 28617997
[TBL] [Abstract][Full Text] [Related]
4. E-Cigarettes: A Review of New Trends in Cannabis Use.
Giroud C; de Cesare M; Berthet A; Varlet V; Concha-Lozano N; Favrat B
Int J Environ Res Public Health; 2015 Aug; 12(8):9988-10008. PubMed ID: 26308021
[TBL] [Abstract][Full Text] [Related]
5. Safer scoring? Cryptomarkets, social supply and drug market violence.
Barratt MJ; Ferris JA; Winstock AR
Int J Drug Policy; 2016 Sep; 35():24-31. PubMed ID: 27241015
[TBL] [Abstract][Full Text] [Related]
6. Comparing cryptomarkets for drugs. A characterisation of sellers and buyers over time.
Tzanetakis M
Int J Drug Policy; 2018 Jun; 56():176-186. PubMed ID: 29449105
[TBL] [Abstract][Full Text] [Related]
7. Who sells what? Country specific differences in substance availability on the Agora cryptomarket.
Van Buskirk J; Naicker S; Roxburgh A; Bruno R; Burns L
Int J Drug Policy; 2016 Sep; 35():16-23. PubMed ID: 27520115
[TBL] [Abstract][Full Text] [Related]
8. Should we smoke it for you as well? An ethnographic analysis of a drug cryptomarket environment.
Kowalski M; Hooker C; Barratt MJ
Int J Drug Policy; 2019 Nov; 73():245-254. PubMed ID: 31054880
[TBL] [Abstract][Full Text] [Related]
9. Adolescent nicotine and marijuana vaping activity and the use of other illicit substances.
Boccio CM; Jackson DB
Drug Alcohol Depend; 2021 Feb; 219():108469. PubMed ID: 33360850
[TBL] [Abstract][Full Text] [Related]
10. Exploring Differences in Daily Vaping of Nicotine and Cannabis among People Who Use Drugs in New Zealand.
Rychert M; Romeo JS; Wilkins C
Subst Use Misuse; 2023; 58(11):1388-1398. PubMed ID: 37328432
[No Abstract] [Full Text] [Related]
11. Vaping while high: Factors associated with vaping marijuana among youth in the United States.
Ben Taleb Z; Kalan ME; Bahelah R; Boateng GO; Rahman M; Alshbool FZ
Drug Alcohol Depend; 2020 Dec; 217():108290. PubMed ID: 32956975
[TBL] [Abstract][Full Text] [Related]
12. Reputation transferability across contexts: Maintaining cooperation among anonymous cryptomarket actors when moving between markets.
Norbutas L; Ruiter S; Corten R
Int J Drug Policy; 2020 Feb; 76():102635. PubMed ID: 31972474
[TBL] [Abstract][Full Text] [Related]
13. Delivery dilemmas: How drug cryptomarket users identify and seek to reduce their risk of detection by law enforcement.
Aldridge J; Askew R
Int J Drug Policy; 2017 Mar; 41():101-109. PubMed ID: 28089207
[TBL] [Abstract][Full Text] [Related]
14. The transparency paradox. Building trust, resolving disputes and optimising logistics on conventional and online drugs markets.
Tzanetakis M; Kamphausen G; Werse B; von Laufenberg R
Int J Drug Policy; 2016 Sep; 35():58-68. PubMed ID: 26809972
[TBL] [Abstract][Full Text] [Related]
15. New psychoactive substances (NPS) on cryptomarket fora: An exploratory study of characteristics of forum activity between NPS buyers and vendors.
Van Hout MC; Hearne E
Int J Drug Policy; 2017 Feb; 40():102-110. PubMed ID: 28027812
[TBL] [Abstract][Full Text] [Related]
16. Identification of Vape Shops in Two North Carolina Counties: An Approach for States without Retailer Licensing.
Lee JG; D'Angelo H; Kuteh JD; Martin RJ
Int J Environ Res Public Health; 2016 Oct; 13(11):. PubMed ID: 27801793
[TBL] [Abstract][Full Text] [Related]
17. Illicit drug prices and quantity discounts: A comparison between a cryptomarket, social media, and police data.
Moeller K; Munksgaard R; Demant J
Int J Drug Policy; 2021 May; 91():102969. PubMed ID: 33041184
[TBL] [Abstract][Full Text] [Related]
18. A cloud on the horizon-a survey into the use of electronic vaping devices for recreational drug and new psychoactive substance (NPS) administration.
Blundell M; Dargan P; Wood D
QJM; 2018 Jan; 111(1):9-14. PubMed ID: 29025078
[TBL] [Abstract][Full Text] [Related]
19. Going international? Risk taking by cryptomarket drug vendors.
Décary-Hétu D; Paquet-Clouston M; Aldridge J
Int J Drug Policy; 2016 Sep; 35():69-76. PubMed ID: 27453145
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and correlates of vaping cannabis in a sample of young adults.
Jones CB; Hill ML; Pardini DA; Meier MH
Psychol Addict Behav; 2016 Dec; 30(8):915-921. PubMed ID: 27631612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
